Preliminary crystallographic data for Bowman-Birk inhibitor from soybean seeds

Area of Science:

• Biochemistry
• Crystallography
• Plant Science

Background:

• The Bowman-Birk inhibitor (BBI) is a well-characterized soybean protease inhibitor.
• Protease inhibitors play crucial roles in plant defense mechanisms and have potential applications in human health.

Purpose of the Study:

• To determine the crystal structure of the soybean Bowman-Birk inhibitor.
• To characterize the crystallization conditions and structural properties of BBI.

Main Methods:

• Crystallization of BBI using polyethylene glycol 4000 and vapor diffusion.
• X-ray diffraction analysis to determine unit cell dimensions and space group.
• Characterization of crystal stability and solvent content.

Main Results:

• BBI crystallized in a hexagonal unit cell (space group P6122 or P6522) with dimensions a = b = 91.36 Å and c = 63.92 Å.
• The crystal contains 2 molecules of BBI (MW 8000) per asymmetric unit, totaling 12 molecules.
• The crystal diffracted to 3-Å resolution, showed stability to X-irradiation, and had ~52% solvent content.

Conclusions:

• Successful crystallization and structural determination of soybean Bowman-Birk inhibitor were achieved.
• The crystallographic data provide a foundation for understanding BBI's structure-function relationship.
• These findings contribute to the broader knowledge of plant-derived protease inhibitors.